Clinical Trial Update: Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects [Phase 3]

View source ↗

Summary

The Phase 3 STACK study of quetiapine (Seroquel) for schizophrenia or schizoaffective disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Schizoaffective Disorders | Phase 3 | Status: COMPLETED